Canine Cushing's Testing: LDDST vs ACTH Stimulation
· By Dr. Tang
TL;DR — There is no single definitive test for canine Cushing’s, and the two workhorses are mirror images. The LDDST (low-dose dexamethasone suppression) is the screening choice — it catches 85–100% of cases and can sometimes separate pituitary from adrenal disease — but its specificity is only 44–73%, so it over-calls in any sick dog. The ACTH stimulation test is more specific but misses about 20% of pituitary and up to 40% of adrenal cases. The strategy that follows: use LDDST to screen, cross-check with ACTH stim when the picture is muddy, and use ACTH stim serially to monitor treatment — where a well-managed dog’s cortisol falls back into range.
In Plain Terms
Cushing’s is the disease of too much cortisol, and it looks obvious — a pot-bellied dog drinking and urinating excessively — yet it is notoriously hard to pin down with a test. The reason is that cortisol is also the stress hormone, so any sick or anxious dog has high cortisol for reasons that have nothing to do with Cushing’s. Every Cushing’s test is really an attempt to ask: “is this high cortisol from a diseased adrenal, or just a stressed, sick dog?”
The Three Tests, Compared
| Test | What it measures | Sensitivity | Specificity | Best use |
|---|---|---|---|---|
| UCCR | Urine cortisol:creatinine ratio | High | Low | Rule-out screening |
| LDDST | Cortisol suppression by dexamethasone | 85–100% | 44–73% | Screening of choice |
| ACTH stim | Adrenal response to ACTH | 60–85% | 85–90% | Monitoring, concurrent illness |
The headline: LDDST catches more cases but over-calls; ACTH stim is cleaner but misses more. Neither is a standalone answer, which is the single most important thing to understand before ordering either.
LDDST: The Sensitive Screener
The LDDST tests the feedback loop: give a low dose of dexamethasone (a synthetic steroid), and a normal dog’s cortisol should suppress. A dog with Cushing’s fails to suppress — the adrenals keep pumping cortisol despite the signal to stop.
- Sensitivity 85–100% — it catches almost all cases.
- Specificity 44–73% — but it also flags many dogs with other illnesses, because non-adrenal disease can also disrupt suppression.
The practical upshot: the LDDST is the screening test of choice when Cushing’s is genuinely suspected, and a bonus is that it can sometimes distinguish pituitary from adrenal disease (a distinction that matters for treatment). But a positive LDDST alone is not a diagnosis — it is an invitation to confirm.
ACTH Stim: The Specific Confirmer
The ACTH stimulation test measures how much cortisol the adrenals produce when poked with synthetic ACTH. A normal adrenal responds; a hyperplastic or tumourous one over-responds.
- Sensitivity 60–85% — it misses about 20% of pituitary-dependent cases and up to 40% of adrenal-tumour cases (one source cites a 41% false-negative rate in adrenal disease).
- Specificity 85–90% — a positive is more trustworthy than a positive LDDST.
Its two decisive advantages: it is the monitoring test (serial ACTH stims track whether trilostane/mitotane is working), and it is less distorted by concurrent illness — so it is the preferred test in a diabetic or otherwise sick dog.
The Mirror-Image Trap
The failure modes are symmetric:
- LDDST over-calls — a sick dog with a disrupted feedback loop tests positive without having Cushing’s. Treating on an LDDST alone risks treating a disease the dog does not have.
- ACTH stim under-calls — about 10% of Cushing’s dogs have a normal LDDST, and ~20% a normal ACTH stim, especially early in the disease before adrenal hyperplasia has developed.
The resolution: use both, cross-check, and re-test. A suggestive dog with a negative test is re-tested in 3–6 months if signs progress — not written off.
Prognosis: Why Testing Still Pays
The payoff for getting the diagnosis right is substantial:
- Pituitary-dependent disease (PDH) — the common form (~85% of cases) — median survival up to 30 months with treatment.
- Adrenal-dependent disease (ADH) — median survival ~14 months.
The diagnosis also decides how to treat (trilostane for most, surgery for some adrenal tumours), and serial ACTH stimulation testing is what keeps the dose right. Cushing’s is a chronic, managed disease — the testing never really stops; it just shifts from diagnosis to monitoring.
How the Test Runs
- Confirm the suspicion with signalment + signs + routine bloodwork (elevated ALP is the classic clue).
- Screen with LDDST (or UCCR to rule out).
- Cross-check a positive LDDST with ACTH stim, especially in a sick dog.
- Once diagnosed and treated, monitor with serial ACTH stimulation tests.
Related products: Canine Cortisol Test · FIA680 Analyzer · FIA880 Analyzer
FAQ
Is there a single definitive Cushing’s test?
No — diagnosis combines signs, bloodwork and a sequence of tests (UCCR, LDDST at 85–100% sensitivity, ACTH stim), each with a different profile.
How good is the LDDST?
85–100% sensitive but only 44–73% specific — it catches nearly all cases but over-calls in sick dogs. A positive alone is not a diagnosis.
When is ACTH stim used?
For monitoring treatment and in concurrent illness — more specific (85–90%) but misses 20% pituitary and up to 40% adrenal cases.
Why do the tests disagree?
They measure different things — suppression feedback (LDDST) vs adrenal output (ACTH stim, which misses 20–40% of cases). Early or adrenal Cushing’s can slip past ACTH stim.
What’s the prognosis?
Median survival ~14 months (ADH) and up to 30 months (PDH) with treatment.
What if tests are normal but I still suspect Cushing’s?
Retest in 3–6 months — ~10% have a normal LDDST and ~20% a normal ACTH stim, especially early disease.
Key Takeaways
- No single test is definitive — LDDST (85–100% sens / 44–73% spec) and ACTH stim (60–85% / 85–90%) are mirror images, used in sequence.
- LDDST screens, ACTH confirms and monitors — LDDST (85–100% sens) catches the case, ACTH stim (60–85% sens) cross-checks and then tracks treatment.
- Both miss in opposite directions — LDDST over-calls in sick dogs; ACTH stim misses 20–40%, especially adrenal tumours and early disease.
- Re-test, don’t abandon — a suggestive dog with a normal test is re-checked in 3–6 months, not written off.
- The diagnosis buys survival — treated PDH median 30 months vs ADH 14 months; and the testing never stops — it shifts to monitoring.
References
- Behrend EN, et al. ACVIM consensus statement: Diagnosis of spontaneous canine hyperadrenocorticism. J Vet Intern Med. 2013.
- Bennaim M, et al. Diagnosis of naturally occurring Cushing’s syndrome by primary care veterinarians. J Vet Intern Med.
- PetMD / dvm360. ACTH stimulation and LDDST for canine Cushing’s.
This content is for educational and product-selection purposes only. It is not a substitute for veterinary diagnosis — a dog with suspected Cushing’s should be evaluated by a veterinarian. Reference ranges are platform-dependent; always use the intervals validated for your specific analyzer. Product specifications are as published by Migibio (Guangzhou Magic Biotech Co., Ltd.) and may change.